Pattern Bioscience Surpasses 1,000 Samples in Multi-Center Clinical Trial of Rapid Pneumonia Diagnostic

Milestone marks the half-way point of enrollment in pivotal U.S. study designed to support 510(k) submission for the first culture-free, rapid phenotypic ID/AST panel for critically ill pneumonia patients AUSTIN, Texas, March 19, 2026 — Pattern Bioscience, an innovator in rapid diagnostic technologies for bacterial infections, today announced that more than 1,000 samples have been […] The post Pattern Bioscience Surpasses 1,000 Samples in Multi-Center Clinical Trial of Rapid Pneumonia Diagnostic appeared first on Pattern Bioscience .